A detailed history of New Edge Advisors, LLC transactions in Kempharm, Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 4,024 shares of KMPH stock, worth $19,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,024
Previous 4,474 10.06%
Holding current value
$19,878
Previous $22,000 13.64%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
N/A
-450 Reduced 10.06%
4,024 $19,000
Q4 2023

Feb 13, 2024

SELL
N/A
-426 Reduced 8.69%
4,474 $22,000
Q2 2023

Aug 14, 2023

SELL
$4.94 - $6.29 $1,482 - $1,887
-300 Reduced 5.77%
4,900 $24,000
Q1 2023

May 12, 2023

SELL
$4.13 - $6.27 $4,130 - $6,270
-1,000 Reduced 16.13%
5,200 $28,000
Q4 2022

Feb 14, 2023

BUY
$4.12 - $5.62 $25,544 - $34,844
6,200 New
6,200 $28,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.